PROTHROMBIN GENE MUTATION DETECTION
MRP - ₹ -1 3,600
What is a PROTHROMBIN GENE MUTATION DETECTION?
The Prothrombin Gene Mutation Detection test is a genetic analysis that identifies mutations in the F2 gene, specifically the G20210A variant, which increases the risk of abnormal blood clot formation. This mutation can predispose individuals to deep vein thrombosis, pulmonary embolism, or other clotting disorders. The purpose of this test is to confirm genetic susceptibility, guide preventive measures, and help clinicians tailor treatment strategies for patients with unexplained clotting events or a family history of thrombophilia.
Additional Information
| Also known as/ Other names: | Prothrombin G20210A Mutation Test, Factor II Mutation Analysis, Prothrombin Gene PCR Test, Factor II (Prothrombin) Gene Mutation Test |
| Parameters: | 1 |
| Recommended for: | M/F/Others |
| Sample Type: | Blood |
| Patient Preparation: | No prior preparation is needed |
| Reports: | 3 working days |
FAQs
It helps confirm genetic susceptibility to thrombophilia, guiding preventive measures and treatment strategies for patients with unexplained clotting events or family history of clotting disorders.
Patients with recurrent deep vein thrombosis, pulmonary embolism, or family history of clotting disorders may be recommended for testing.
A positive result indicates increased risk of clotting, guiding preventive care and treatment decisions.
A negative result suggests no detectable prothrombin gene mutation, reducing likelihood of inherited thrombophilia.
No, medications do not interfere with genetic mutation detection.
Yes, it is safe and can be performed in pediatric patients when clinically indicated.
Without testing, genetic clotting risks may remain undiagnosed, leading to life-threatening events like pulmonary embolism.
While the mutation cannot be prevented, early detection allows lifestyle changes and medical interventions to reduce risks.
